Table 4.
Linear regression models for the association between MoCA scores and characteristics of OSA or RBD
MoCA linear regression | β | 95% confidence internal | P |
---|---|---|---|
OSA | |||
Unadjusted | −0.722 | −1.544 to 0.101 | 0.085 |
Model 1 | −0.584 | −1.395 to 0.228 | 0.157 |
Model 2 | −0.574 | −1.395 to 0.247 | 0.169 |
Model 3 | −0.736 | −1.447 to −0.025 | 0.043 |
RBD | |||
Unadjusted | −2.480 | −3.179 to −1.781 | <0.001 |
Model 1 | −2.429 | −3.088 to −1.771 | <0.001 |
Model 2 | −2.445 | −3.106 to −1.784 | <0.001 |
Model 3 | −2.575 | −3.231 to −1.920 | <0.001 |
AHI | |||
Unadjusted | −0.054 | −0.087 to −0.021 | 0.002 |
Model 1 | −0.046 | −0.079 to −0.012 | 0.008 |
Model 2 | −0.046 | −0.080 to −0.012 | 0.008 |
Model 3 | −0.052 | −0.081 to −0.024 | <0.001 |
ODI | |||
Unadjusted | −0.061 | −0.094 to −0.028 | <0.001 |
Model 1 | −0.054 | −0.087 to −0.020 | 0.002 |
Model 2 | −0.054 | −0.088 to −0.020 | 0.002 |
Model 3 | −0.060 | −0.089 to −0.031 | <0.001 |
Tonic EMG activity | |||
Unadjusted | −0.059 | −0.100 to −0.019 | 0.005 |
Model 1 | −0.057 | −0.104 to −0.011 | 0.016 |
Model 2 | −0.059 | −0.105 to −0.012 | 0.016 |
Model 3 | −0.065 | −0.119 to −0.012 | 0.017 |
Phasic EMG activity | |||
Unadjusted | −0.046 | −0.087 to −0.004 | 0.031 |
Model 1 | −0.043 | −0.088 to 0.001 | 0.057 |
Model 2 | −0.047 | −0.093 to −0.002 | 0.043 |
Model 3 | −0.051 | −0.102 to −0.001 | 0.049 |
Model 1: Adjusted for age, duration, education, and BMI; Model 2: Adjusted for age, duration, education, BMI, UPDRS III score, and Levodopa-equivalent daily dosage; Model 3: Adjusted for age, duration, education, BMI, UPDRS III score, Levodopa-equivalent daily dosage, insomnia, restless legs syndrome, RBD, or OSA. MoCA: Montreal Cognitive Assessment; OSA: Obstructive sleep apnea; RBD: Rapid eye movement sleep behavior disorder; AHI: Apnea-hypopnea index; ODI: Oxygen desaturation index; EMG: Electromyography; BMI: Body mass index; UPDRS: Unified Parkinson’s Disease Rating Scale.